{"id":79832,"date":"2025-10-13T17:56:27","date_gmt":"2025-10-13T16:56:27","guid":{"rendered":"https:\/\/dknews.dz\/?p=79832"},"modified":"2025-10-13T17:56:29","modified_gmt":"2025-10-13T16:56:29","slug":"industrie-pharmaceutique-accord-entre-saidal-et-novo-nordisk-algerie-pour-le-developpement-de-traitements-innovants","status":"publish","type":"post","link":"https:\/\/dknews.dz\/index.php\/2025\/10\/13\/industrie-pharmaceutique-accord-entre-saidal-et-novo-nordisk-algerie-pour-le-developpement-de-traitements-innovants\/","title":{"rendered":"Industrie pharmaceutique : accord entre \u00ab\u00a0Saidal\u00a0\u00bb et \u00ab\u00a0Novo Nordisk Alg\u00e9rie\u00a0\u00bb pour le d\u00e9veloppement de traitements innovants"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<p>Le groupe Saidal a sign\u00e9, lundi \u00e0 Alger, un protocole d'\u00a0\u00bbaccord strat\u00e9gique\u00a0\u00bb avec \u00ab\u00a0Novo Nordisk Alg\u00e9rie\u00a0\u00bb en vue de d\u00e9velopper la production et la distribution de traitements innovants en Alg\u00e9rie, notamment les insulines de derni\u00e8re g\u00e9n\u00e9ration, indique un communiqu\u00e9 du groupe public. La c\u00e9r\u00e9monie de signature s&rsquo;est tenue au si\u00e8ge de la direction g\u00e9n\u00e9rale de Saidal, en pr\u00e9sence de sa directrice g\u00e9n\u00e9rale, Nabila Benygzer, du directeur g\u00e9n\u00e9ral de Novo Nordisk Alg\u00e9rie, Hamza Benharkat, ainsi que de cadres des deux entreprises, pr\u00e9cise la m\u00eame source. Cet accord \u00ab\u00a0ambitieux\u00a0\u00bb porte sur le d\u00e9veloppement conjoint de la production et de la distribution de mol\u00e9cules innovantes, incluant les insulines de derni\u00e8re g\u00e9n\u00e9ration de Novo Nordisk. Selon le communiqu\u00e9, il marque \u00ab\u00a0une \u00e9tape majeure\u00a0\u00bb vers la mise en \u0153uvre d&rsquo;une production aseptique dite full process en Alg\u00e9rie, fruit d&rsquo;un partenariat technologique entre les deux entreprises. Saidal a soulign\u00e9 que ce \u00ab\u00a0partenariat gagnant-gagnant\u00a0\u00bb, issu d&rsquo;une vision commune des dirigeants des deux groupes, repose sur le transfert de savoir-faire et de technologie. Novo Nordisk est, rappelle-t-on, un \u00ab\u00a0leader mondial dans l&rsquo;innovation th\u00e9rapeutique dans le domaine des maladies chroniques, notamment le diab\u00e8te et l&rsquo;ob\u00e9sit\u00e9\u00a0\u00bb. <\/p>\n\n\n\n<p>Cet accord ouvre \u00e9galement \u00ab\u00a0de nouvelles perspectives de d\u00e9veloppement durable pour les deux compagnies\u00a0\u00bb et \u00ab\u00a0renforce significativement les capacit\u00e9s locales de production pharmaceutique\u00a0\u00bb, contribuant ainsi aux efforts des autorit\u00e9s pour assurer la souverainet\u00e9 sanitaire nationale. \u00ab\u00a0En alliant l&rsquo;expertise de Novo Nordisk en recherche et d\u00e9veloppement \u00e0 l&rsquo;exp\u00e9rience industrielle et \u00e0 l&rsquo;ancrage solide de Saidal dans le tissu pharmaceutique national, cette alliance strat\u00e9gique profitera avant tout aux patients alg\u00e9riens\u00a0\u00bb, souligne encore le communiqu\u00e9, pr\u00e9cisant qu&rsquo;elle garantira \u00ab\u00a0un meilleur acc\u00e8s \u00e0 des traitements innovants, s\u00fbrs et de haute qualit\u00e9 r\u00e9pondant aux standards internationaux les plus exigeants\u00a0\u00bb.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le groupe Saidal a sign\u00e9, lundi \u00e0 Alger, un protocole d&rsquo;\u00a0\u00bbaccord strat\u00e9gique\u00a0\u00bb avec \u00ab\u00a0Novo Nordisk Alg\u00e9rie\u00a0\u00bb en vue de d\u00e9velopper la production et la distribution de traitements innovants en Alg\u00e9rie, notamment les insulines de derni\u00e8re g\u00e9n\u00e9ration, indique un communiqu\u00e9 du groupe public. La c\u00e9r\u00e9monie de signature s&rsquo;est tenue au si\u00e8ge de la direction g\u00e9n\u00e9rale de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":79833,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[107],"tags":[],"ppma_author":[163],"class_list":{"0":"post-79832","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-economie"},"authors":[{"term_id":163,"user_id":1,"is_guest":0,"slug":"dknews","display_name":"dknews","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/f56c36580f44a9d8e8535169273499b7dddc82045bcc254bf7d154ff6b485f62?s=96&d=mm&r=g","first_name":"","last_name":"","user_url":"https:\/\/dknews.dz","job_title":"","description":""}],"_links":{"self":[{"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/posts\/79832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/comments?post=79832"}],"version-history":[{"count":0,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/posts\/79832\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/media\/79833"}],"wp:attachment":[{"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/media?parent=79832"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/categories?post=79832"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/tags?post=79832"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/ppma_author?post=79832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}